Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Clinical Results of Proton Beam Therapy for Esophageal Cancer

07/07/2019
/ Publications

A large retrospective study of 202 patients (90 inoperable patients and 100 patients (49.5%) had stage III/IV cancer) who were treated with PBT in Japan. This...

Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced NSCLC patients treated with concurrent chemoradiotherapy

03/06/2019
/ Publications

This study evaluated pre-treatment and post-treatment F-FDG PET/CT of 18 locally advanced NSCLC patients treated with definitive photon or proton RT. In nine...

Hypofractionated PBT for centrally located lung cancer.

03/05/2019
/ Publications
/
Hypofractionation

This study from Japan reported outcomes of 39 patients who received hypofractionated PBT for centrally located cT1-2N0M0. Twenty-four patients (62%) were...

Clinical outcomes after IMPT with concurrent chemotherapy for inoperable NSCLC.

03/04/2019
/ Publications
/
Chemotherapy

Published in the Green Journal, this study by MD Anderson reported disease control, survival, and toxicity in patients with advanced inoperable non-small cell...

Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.

10/10/2020
/ Publications
/
Toxicity
IMPT

This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...

PBT is a safe and feasible treatment for patients with second primary lung cancer after lung resection.

10/12/2018
/ Publications

A study from Japan reported 19 patients who were diagnosed with second primary lung cancer after lung resection, underwent PBT. This study reported the three...

Impact of unfavorable factors on outcomes among inoperable stage II-IV NSCLC patients treated with PT.

01/01/2019
/ Publications

A study by the Jacksonville group. 90 consecutive patients with unresectable stage II-IV (oligometastatic) NSCLC were treated with PT. Unfavorable factors...

Preliminary result of definitive radiotherapy in patients with NSCLC who have underlying idiopathic pulmonary fibrosis

01/01/2019
/ Publications
/
Survival

Idiopathic pulmonary fibrosis (IPF) is associated with fatal complications after radiotherapy (RT) for lung cancer patients. This study evaluated 264 patients...

Proton Therapy in NSCLC

11/11/2018
/ Publications
/
IMPT
Immunotherapy

A review on PBT for NSCLC. The review pointed out that despite early results suggesting improvements or at least comparable outcomes, the most recent randomized...

Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk than Mean Lung Dose

08/08/2018
/ Publications

Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 203 patients treated with protons or IMRT to 66-74 Gy(RBE) in 33-37...